About Converge Bio
Converge Bio is a private company based in Claymont, Delaware, incorporated in 2024 in Delaware. It has reported $25,000,000 raised in one offering on Form D since April 2026. Its chief executive is Dov Gertz.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 24, 2025 | Apr 28, 2026 | $25,000,000fully sold | 19 | $1.3M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Converge Bio's Form D filed Apr 28, 2026.
Sources
- SECConverge Bio Inc. filing history
- CompanyAbout Converge Bio
- CompanyTerms of Use
- CompanyConvergeAB antibody study